NasdaqGS - Delayed Quote USD

Y-mAbs Therapeutics, Inc. (YMAB)

4.1300
+0.0100
+(0.24%)
At close: April 24 at 4:00:01 PM EDT
4.0685
-0.06
(-1.49%)
After hours: April 24 at 5:54:14 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
119,904
127,869
141,456
212,783
Total Liabilities Net Minority Interest
27,900
26,884
32,235
32,677
Total Equity Gross Minority Interest
92,004
100,985
109,221
180,106
Total Capitalization
92,004
100,985
109,221
180,106
Common Stock Equity
92,004
100,985
109,221
180,106
Capital Lease Obligations
820
1,419
1,767
3,634
Net Tangible Assets
89,728
98,354
106,235
178,443
Working Capital
74,811
90,983
102,163
174,386
Invested Capital
92,004
100,985
109,221
180,106
Tangible Book Value
89,728
98,354
106,235
178,443
Total Debt
820
1,419
1,767
3,634
Share Issued
44,988.3130
43,672.1120
43,670.1090
43,694.7160
Ordinary Shares Number
44,988.3130
43,672.1120
43,670.1090
43,694.7160
12/31/2021 - 9/21/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STOK Stoke Therapeutics, Inc.
9.88
+3.78%
 
SGMT Sagimet Biosciences Inc.
3.1200
+12.43%
 
BCYC Bicycle Therapeutics plc
8.60
-0.81%
 
RVMD Revolution Medicines, Inc.
38.58
+3.04%
 
REPL Replimune Group, Inc.
9.06
+2.60%
 
CRNX Crinetics Pharmaceuticals, Inc.
33.39
+3.15%
 
STRO Sutro Biopharma, Inc.
1.3000
+44.44%
 
ALEC Alector, Inc.
1.1800
+1.72%
 
ASND Ascendis Pharma A/S
160.45
+1.46%
 
RENB Renovaro Inc.
0.3728
-0.75%